Saturday, 14 June 2014
Academic
literature, research and science receive great services from scholarly
publishing. The industry is majorly dominated by subscription-based publishing
which has existed for as long as the scholarly journals publishing it (Paul
Peters, 2007). Academic journals and the quality of the research published in
these journals are judged by their impact factor; a measure of the number of
citation to articles published in the journals.
Bentham
Science is a fast growing scholarly journals publishers and has been serving
the libraries and academia for the past 3 decades. They have approximately
published 122 subscription based journals, while their flagship products
include 32 High Impact Factor Journals.
1.
Current Genre
therapy is a bi-monthly peer-reviewed
journal, with an impact factor as high as 5.
This journal aims to target academic and industrial researchers and
scientists interested in major topics concerning basic and clinical application
of gene and cell therapy. It publishes original and latest developments in gene
transfers and gene expression analysis, as well as human clinical applications
amongst other topics.
2.
Current Drug Metabolism has an impact factor of 4.04. It aims to cover all
the outstanding research developments in drug metabolism. The journal,
moreover, acts as an international forum for the publication of timely reviews
and guest edited issues in drug metabolism.
